ARTICULO ORIGINAL
REVISTA DE LA FACULTAD DE MEDICINA HUMANA 2021 - Universidad Ricardo Palma
1 Instituto de Investigaciones en Ciencias Biomédicas, Universidad Ricardo Palma.
2 Universidad Tecnológica del Perú, Lima, Perú.
3 Latin American Lifestyle Medicine Association.
ABSTRACT
Objectives: To determine the diagnostic performance of the lipid accumulation product (LAP), visceral adiposity index (VAI), triglyceride and glucose index (TyG) and body mass index (BMI) for metabolic syndrome (MetS) in a sample of Peruvian adults. Methodology: Study of diagnostic tests of the “National Survey on Nutritional, Biochemical, Socioeconomic, and Cultural Indicators related with Chronic Degenerative Diseases”. An analysis of ROC curves (Receptor Operation) was made, and their respective area under the curve (AUC) obtaining the different parameters such as sensitivity (Sens) and specificity (Spe). It was stratified according to sex and according to age. To choose the cut-off point, the Youden index was used. Results: The LAP had the highest AUC in both men (AUC = 0.929; cut-off value = 59.85; Sens = 91.6 and Spe = 84.5) and for women (AUC = 0.950; cut-off value = 53, 06; Sens = 92.4 and Spe = 86.4). The second place, in the case of men, was occupied by the VAI (AUC = 0.905; cut-off value = 2.36; Sens = 91.6 and Spe = 79.7), while in the case of women it was the TyG (AUC = 0.914; cut-off value = 8.70; Sens = 87.4 and Spe = 87.3). The LAP index showed significant differences with VAI to predict MetS (p < 0.05), while no differences were shown with TyG. Conclusion: The LAP index had the best diagnostic performance for MetS, both for men and women, regardless of age.
Keywords: Metabolic syndrome, triglycerides, glucose, product of lipid accumulation, body mass index (Source : MeSH - NLM).
RESUMEN
Objetivos: Determinar el rendimiento diagnóstico del producto de acumulación de lípidos (LAP), índice de adiposidad visceral (VAI), índice de triglicéridos y glucosa (TyG) e índice de masa corporal (IMC) para síndrome metabólico (SMet) en una muestra de adultos peruanos. Metodología: Estudio de pruebas diagnósticas de la “Encuesta Nacional de Indicadores Nutricionales, Bioquímicos, Socioeconómicos y Culturales relacionados con las Enfermedades Crónicas-Degenerativas”. Se hizo un análisis de curvas ROC (Operativa del Receptor), y su respectiva área bajo la curva (AUC) obteniendo los diferentes parámetros como sensibilidad (Sens) y especificidad (Esp). Se estratificó según sexo y según la edad. Para escoger el punto de corte se utilizó el índice de Youden. Resultados: El LAP tuvo el mayor AUC tanto en hombres (AUC = 0,929; valor de corte = 59,85; Sens = 91,6 y Esp = 84,5) como para mujeres (AUC = 0,950; valor de corte = 53,06; Sens = 92,4 y Esp = 86,4). El segundo lugar, en el caso de los hombres, lo ocupó el VAI (AUC = 0,905; valor de corte = 2,36; Sens = 91,6 y Esp = 79,7), mientras que en el caso de las mujeres lo fue el TyG (AUC = 0,914; valor de corte = 8,70; Sens = 87,4 y Esp = 87,3). El índice LAP mostró diferencias significativas con VAI para predecir SMet (p < 0,05), mientras que no se mostraron diferencias con TyG. Conclusión: El índice LAP tuvo el mejor rendimiento diagnóstico para SMet, tanto a hombres y mujeres, independiente de la edad.
Palabras Clave: Síndrome metabólico, triglicéridos, glucosa, producto de la acumulación de lípidos, índice de masa corporal (Fuente: DeCS BIREME).
INTRODUCTION
Metabolic syndrome (SMet) is a clinical state that includes central obesity, hypertension,
hyperglycemia, and dyslipidemia. The presence of SMet long term increases the risk of developing
cardiovascular disease and diabetes mellitus (1,2).
The prevalence in the world of SMet varies. In China, around 32.4% is found (3), while in the United States it is 34.7 (4). In
Latin America, a systemic revision reported a prevalence of 24.9%, more frequent among women than men
(5). In Peru, a consensus does not exist (6),
prevalence levels fluctuating between 20 to 47% (7-9).
SMet diagnosis is not complex, but we don’t always have the five criteria at hand, even more so
in low-income areas (10). For this reason, it is important to find simpler
indicators to detect SMet. The ones that have shown a good diagnostic performance are triglyceride and
glucose index (TyG) (11-14), and the lipid accumulation indices, such as
lipid accumulation product (LAP) and visceral adiposity index (VAI). Body mass index (BMI) has also been
studied (15-18).
These indicators have shown different cutting points and predictive capacity according to
location where research took place (13,19-21). For this reason, the objective of this study is to
determine the diagnostic performance of LAP, VAI, TyG and BMI for SMet confirmed in a sample of adult
Peruvian inhabitants.
MATERIALS AND METHODS
Design and area of study
Diagnostic test studies. Data base analysis secondary to “National Survey on Nutritional, Biochemical, Socioeconomic, and Cultural Indicators related with Chronic Degenerative Diseases” (NSNBSCI), performed between the years 2004 – 2005 (22). The purpose of this survey was to learn the prevalence of chronic diseases of metabolic origin, such as metabolic syndrome, lipid disorders, type 2 diabetes mellitus, and arterial hypertension.
Study population
The original study was carried out nationally, divided into five areas: Metropolitan Lima, the remainder
of the Coast, Urban Mountains, Rural Mountains and Jungle. It was composed of everyone above or equal to
20 years of age, that resided in that location at the time of the survey.
The NSNBSCI had a multistage design. Clusters were selected in each level, by simple random
sample, and within each one, blocks, houses, and people were selected. The sample unit was the housing
of clusters, and the unit of analysis was the people with the beforementioned characteristics.
Additional information about selection criteria, sample size and all variables that were taken have been
published elsewhere (22).
In this study we included only the subjects who had the complete data on variables of interest,
and whose laboratory or anthropometric values were within the biologically plausible lower limits.
Variables and measures
The main variable for the diagnosis was Smet. We considered SMet through the criteria of the National
Education Program on Cholesterol Adult Treatment Panel III (ATPIII) Programa Nacional de Educación sobre
el Colesterol Panel de Tratamiento de Adultos III (ATPIII) (23). In the case
of ATPIII, SMet is diagnosed by presenting three or more of the following alterations: abdominal obesity
obtained with the abdominal circumference (AC) ≥ 88 cm for women or ≥ 102 cm for men;
hypertriglyceridemia (triglycerides ≥ 150 mg/dl); hyperglycemia (fasting glucose ≥ 100 mg/dl or if they
receive treatment to lower glucose levels); high blood pressure (systolic blood pressure ≥ 130 mmHg or
diastolic blood pressure ≥ 85 mmHg or receive treatment to lower blood pressure levels); low HDL
(HDL-cholesterol < 50 mg/dl in women or < 40 mg/dl in men).
There were four variables considered to test their diagnostic performance (Table 1):
Table 1. Predictive equations to calculate metabolic syndrome
Index | Equation | ||
---|---|---|---|
BMI* | Weight (Kg) / height2 (meters) | ||
TyG** | Ln (TG [mg/dL] x fasting glucose (mg/dL)/2) | ||
VAI*** | Men (AC/[39.68 + (1.88 x BMI)]) x (triglycerides/1.03) x (1.31/HDL-cholesterol) | Women (AC/[36.58 + (1.89 x BMI)]) x (triglycerides/0.81) x (1.52/HDL-cholesterol) | |
LAP**** | Men (AC - 65) x TG | Women (AC - 58) x TG | |
*Body Mass Index **Triglyceride and Glucose index ***Visceral adiposity index ****Lipid Accumulation Product |
AC values lower than 65 and 58 cm in women and men were reassigned to 66 and 59 cm, in order to avoid
invalid data. For VAI and LAP, TG and HDL in mmol/L were presented. The other variables included in the
study were age (in years), body mass index (BMI), smoker state (if they have ever smoked “yes” or “no”),
alcohol drinker (if they have ever had an alcoholic drink “yes” or ”no”), and physical activity (do you
practice physical activity outside of your work “yes” or “no”).
In NSNBSCI, the anthropometric measures were obtained using a mobile wooden measure and a
standing digital balance of Sohenle Brand with 120 kg capacity and specificity of 0.1 kg. Once the
weight and height are obtained, we proceeded to calculate BMI applying the corresponding formula: Weight
(kg) /Height2 (m). The waist perimeter was measured with a flexible measuring tape at the middle point
between the lower edge of the ribs and the iliac crest, passing by the half centimeter closest to the
navel. The blood pressure measures were performed using a Mac-Check-501 sphygmomanometer.
The subject was asked to have a minimum fasting of 8 hours to obtain the biochemical samples.
The blood samples were taken through a vacuum system with a gel clot activator. We obtained the blood
using Handzentrifuge manual centrifuges of 3000 RPM and cryovials that allowed the safe transfer and
conservation of the samples. Glucose was obtained based on an enzymatic Trinder-GOD-PAD (glucose
oxidase) method, and HDL-cholesterol was obtained through an enzymatic Trinder-Colorimetric method.
Statistical analysis
STATA v16.0 statistical software was used. For this analysis, we stratified according to sex. In the
bivariate analysis, considering the SMet outcome, Chi square teste of independence was used for the
categorical covariables, while the Mann Whitney U-test for the numerical covariables, since they did not
present normal distribution, which was evaluated through bias, kurtosis, and histogram.
In order to evaluate the discriminative diagnostic performance, we used ROC curve analysis
(Receiver Operating Characteristic) and its respective area under the curve (AUC) as statistical and
graphic method. We calculated sensitivity (Sens), specificity (Spec), positive (PPV) and negative
predictive value (NPV) and positive (LR+) and negative likelihood ratio (LR-). Youden’s index was used
to determine the optimal cut off point. The ROC curve was graphed according to sex and age younger and
older equal to 65 years.
Ethical considerations
This is a secondary analysis of the database with free public access. At the same time, the base is codified, guaranteeing the confidentiality and anonymity of the participants. Therefore, the damage to these subject is minimal.
RESULTS
We worked with a total of 1936 men and 2055 women. Of the total, 24,33% presented SMet, as opposed to
men which was only 5.53%. The average age of men with Smet was greater than the age of women. There were
no differences between both sexes compared to having smoked before and presenting Smet. However, for
women, we found an association between presenting Smet and having ever drank alcohol, but not in men.
The rest of the comparisons, which were statistically significant, are found in table
2.
With relation to ROC analysis and AUC of the 4 indices tested for the identification of SMet,
for both men and women, LAP had the highest AUC for men (AUC = 0.929; cut-off point = 59.85; Sens = 91.6
and Spec = 84.5) as for women (AUC = 0.950; cut-off point = 53.06; Sens = 92.4 and Spec = 86.4). In
second place, for men, VAI index had the highest AUC (AUC = 0.905; cut-off point = 2.36; Sens = 91.6 and
Spec = 79.7), while for women, it was TyG (AUC = 0.914; cut-off point = 8.70; Sens = 87.4 and Spec =
87.3). The LAP index showed significant differences with VAI to predict SMet (p < 0,05), while no
differences were found with TyG. The rest of data are found in Table 3. Figure 1 graphs AUC according to sex and age.
Tabla 2. Comparaciones entre las características clínicas y bioquímicas según el sexo y la presencia de síndrome metabólico SMet: síndrome metabólico, TyG: Índice triglicéridos y glucosa, LAP: el Producto de acumulación de lípidos y VAI: el índice de los adipocitos visceral
Características | Masculino (n = 1936) | Femenino (n = 2055) | ||||
---|---|---|---|---|---|---|
SMet (-) | SMet (+) | valor p | SMet (-) | SMet (+) | valor p | |
Total (%) | 1829 (84,47) | 107 (5,53) | 1555 (75,67) | 500 (24,33) | ||
Edad (años) | 40 (30 - 55) | 52 (39 - 64) | < 0,001 | 36 (27 - 46) | 49 (40 - 58) | < 0,001 |
Índice de masa corporal (Kg/m2) | 23,64 (21,70 - 26,26) | 30,31 (27,83 - 33,18) | < 0,001 | 23,99 (21,71 - 26,32) | 28,88 (26,32 - 31,72) | < 0,001 |
Estado de fumador (%) | 0,231 | 0,861 | ||||
No | 205 (96,24) | 8 (3,76) | 818 (75,05) | 272 (24,95) | ||
Si | 1624 (88,79) | 99 (5,75) | 619 (75,40) | 202 (24,60) | ||
Bebedor de Alcohol (%) | 0,506 | 0,004 | ||||
No | 1796 (94,43) | 106 (5,57) | 1263 (74,21) | 439 (25,79) | ||
Si | 33 (97,06) | 1 (2,94) | 174 (83,25) | 35 (16,75) | ||
Actividad física (%) | 0,001 | 0,011 | ||||
No | 832 (96,41) | 31 (3,59) | 294 (80,33) | 72 (19,67) | ||
Si | 997 (54,51) | 76 (71,03) | 1143 (73,98) | 402 (26,02) | ||
Cintura abdominal (cm) | 87 (80,5 - 94) | 105 (101,7 - 110) | < 0,001 | 84,7 (78,2 - 92) | 97,75 (92,2) | < 0,001 |
Presión arterial sistólica (mmHg) | 110 (100 - 120) | 130 (120 - 140) | < 0,001 | 108 (98 - 112) | 120 (103 - 130) | < 0,001 |
Presión arterial diastólica (mmHg) | 70 (60 - 80) | 80 (70 - 90) | < 0,001 | 68 (60 - 70) | 70 (66,5 - 80) | < 0,001 |
Glucosa (mg/dl) | 80 (75 - 86) | 93 (85 - 109) | < 0,001 | 78 (73 - 84) | 87 (80 - 97) | < 0,001 |
Triglicéridos (mg/dl) | 112 (81 - 157) | 227 (173 - 313) | < 0,001 | 97 (75 - 126) | 196 (244,5) | < 0,001 |
HDL - colesterol (mg/dl) | 42 (40 - 46) | 39 (38 - 41) | < 0,001 | 43 (40 - 48) | 42 (40 - 44) | < 0,001 |
Parámetros para SMet | ||||||
LAP | 25,32 (14,84 - 44,01) | 99,15 (77,53 - 132,24) | < 0,001 | 29,32 (19,78 - 43,33) | 88,01 (68,72 - 116,37) | < 0,001 |
VAI | 1,84 (1,04 - 2,16) | 3,45 (2,60 - 4,74) | < 0,001 | 1,88 (1,43 - 2,50) | 4,07 (3,29 - 5,24) | < 0,001 |
TyG | 8,40 (8,08 - 8,78) | 9,30 (9,10 - 9,59) | < 0,001 | 8,23 (7,96 - 8,85) | 9,07 (8,85 - 9,31) | < 0,001 |
Componentes del SMet | ||||||
Obesidad central (%) | < 0,001 | < 0,001 | ||||
No | 1716 (98,45) | 27 (1,55) | 909 (98,27) | 16 (1,73) | ||
Si | 113 (58,55) | 80 (41,45) | 528 (53,55) | 458 (46,45) | ||
Presión arterial alta (%) | < 0,001 | 29 (1,86) | 86 (17,00) | < 0,001 | ||
No | 1727 (96,48) | 63 (3,52) | 1408 (78,35) | 389 (21,65) | ||
Si | 102 (69,86) | 44 (30,14) | 29 (25,44) | 85 (74,56) | ||
Hiperglicemia (%) | < 0,001 | < 0,001 | ||||
No | 1762 (96,60) | 62 (3,40) | 1417 (79,12) | 374 (20,88) | ||
Si | 67 (59,82) | 45 (40,18) | 20 (16,67) | 100 (83,33) | ||
Hipertrigliceridemia (%) | < 0,001 | < 0,001 | ||||
No | 1320 (99,70) | 4 (0,30) | 1288 (95,20) | 65 (4,80) | ||
Si | 509 (83,17) | 103 (16,83) | 149 (26,70) | 409 (73,30) | ||
Bajo HDL - colesterol (%) | < 0,001 | < 0,001 | ||||
No | 1401 (97,49) | 36 (2,51) | 298 (99,00) | 3 (1,00) | ||
Si | 428 (85,77) | 71 (14,23) | 1139 (70,75) | 471 (29,25) | ||
Los valores numéricos están presentados en mediana y rango intercuartílico |
Tabla 3. Valores diagnósticos del TyG, LAP y VAI en hombres y mujeres para síndrome metabólico.
AUC* (IC 95%) | Punto de corte | Sens %* (IC 95%) | Esp % *(IC 95%) | VVP %* (IC 95%) | VPN %* (IC 95%) | CV+ %* (IC 95%) | CV- %* (IC 95%) | IY* | |
---|---|---|---|---|---|---|---|---|---|
Masculino | |||||||||
VAI** | 0,905 (0,886 - 0,923) | 2,36 | 91,6 (84,6 - 96,1) | 79,7 (77,7 - 81,5) | 20,9 (17,3 - 24,1) | 99,4 (98,9 - 99,7) | 4,50 (4,04 - 5,01) | 0,10 (0,57 - 0,19) | 0,713 |
LAP** | 0,929 (0,907 - 0,952) | 59,85 | 91,6 (84,6 - 96,1) | 84,5 (82,8 - 86,2) | 25,7 (21,4 - 30,4) | 99,4 (98,8 - 99,7) | 5,92 (5,24 - 6,68) | 0,09 (0,05 - 0,18) | 0,761 |
TyG** | 0,913 (0,894 - 0,923) | 8,77 | 96,3 (90,7 - 99,0) | 74,3 (72,2 - 76,3) | 18 (14,9 - 21,4) | 99,7 (99,3 - 99,9) | 3,75 (3,44 - 4,08) | 0,05 (0,02 - 0,13) | 0,708 |
IMC** | 0,878 (0,842 - 0,913) | 26,96 | 83,2 (74,7 - 89,7) | 79,1 (77,1 - 80,9) | 18,9 (15,4 - 22,7) | 98,8 (98,1 - 99,3) | 3,97 (3,51 - 4,49) | 0,21 (0,14 - 0,32) | 0.631 |
Femenino | |||||||||
VAI** | 0,923 (0,909 - 0,937) | 2,92 | 87,6 (84,4 - 90,4) | 86,6 (84,8 - 88,2) | 67,7 (63,9 - 71,3) | 95,6 (94,4 - 96,6) | 6,52 (5,72 - 7,43) | 0,14 (0,11 - 0,18) | 0,748 |
LAP** | 0,950 (0,940 - 0,960) | 53,06 | 92.4 (89,7 - 94,6) | 86,4 (84,6 - 88,1) | 68,6 (65,0 - 72,1) | 97,3 (96,2 - 98,0) | 6,81 (5,99 - 7,74) | 0,09 (0,06 - 0,12) | 0,788 |
TyG** | 0,914 (0,897 - 0,931) | 8,70 | 87,4 (84,2 - 90,2) | 87,3 (85,5 - 88,9) | 68,8 (65,1 - 72,4) | 95,6 (94,4 - 96,6) | 6,86 (6,00 - 7,85) | 0,14 (0,12 - 0,18) | 0,751 |
IMC** | 0,801 (0,781 - 0,822) | 25,75 | 81,6 (77,9 - 84,9) | 67,5 (65,1 – 69,8) | 44,6 (41,4 - 47,9) | 91,9 (90,2 - 93,5) | 2,51 (2,31 - 2,70) | 0,27 (0,23 - 0,33) | 0,021 |
*AUC: área bajo la curva, Sens: sensibilidad, Esp: especificidad, VPP: valor predictivo
positivo, VPN: valor predictivo negativo, CV+: Coeficiente de verosimilitud positivo,
CV-: Coeficiente de verosimilitud negativo y IY: Índice de Youden IC 95%: Intervalo de
confianza al 95%
** VAI: el índice de los adipocitos visceral, LAP: el Producto de acumulación de lípidos, TyG: Índice triglicéridos y glucosa y IMC: Índice de masa corporal |
DISCUSSION
Principle findings
With the objective of finding a better indicator to predict SMet, this study evaluated BMI, LAP< VAI, TyG indices in a sample of adult Peruvian inhabitants. In general, we found that LAP, followed by TyG, were practical parameters to identify SMet, for both men and women and independent of age.
Comparison with other studies
LAP was mentioned first by Khan (24), where it was considered an excessive
marker of lipid accumulation in adults, and very useful for predicting SMet (25). In the current manuscript, LAP was considered the best indicator for
predicting SMet, for their AUC as for their sensitivity and specificity values. These results coincide
with some others found in literature. The study by Chiang and Koo (19) found
that LAP was a better SMet predictor than VAI and TyG in Thai adults older than 50 years of age, with a
cut-off point of 31.6 and with a sensitivity of 88% and 60% for men and women, respectively. In another
study carried out by Spaniards (26) they found the same regarding LAP with
cut-off points of 51.82 and 48.09 with sensitivity of 81 % and 78 % for men and women, respectively. In
the work by Kyung-A y Young-Joo (16), LAP values were the best predictors of
SMet.
The difference with the cut-off points with the current manuscript could be due to ethnic and
biomarker frequency differences that make up LAP and SMet. In the study of 522 healthy Argentinians, by
Tellechea (27), the LAP cut-off point 53.63 demonstrated the greatest precise
diagnosis for SMet, with a sensitivity of 0.83 and specificity of 0.83. In a study in Brazil, although
the cut-off points were different, we must take into account that they used criteria different than
ATPIII (20).
VAI is an important indicator related in an important manner with SMet (28). In this study, LAP occupied second place as a diagnostic predictor of
SMet in men, and third in women, behind TyG. This differs from other research works. In a study of
Iranian population of 35-65 year-olds, Baveicy et al (21) found that VAI had
a greater predictive value for SMet than other biomarkers. The same found in the study by Stefanescu et
al (29), who worked with Peruvian inhabitants, residents of Callao. However,
LAP was not considered among its variables, and it was only a localized population. The same was found
with respect to VAI in the study by Motamed et al (30). The ethnic and
dietary reasons may be involved.
Regarding TyG, no differences were found with AUC. However, LAP sensitivity and specificity
values are better balanced than those of TyG, being more useful the first as a diagnostic test.
Nevertheless, we must consider its role in SMet. Although TyG was studied at first as a
predictor of RI (31), later studies have considered it as an SMet marker. In
the study by Kyung-A and Young-Joo (16), TyG values increased as SMet
component numbers increased. Aslan Çin et al (11) and Anggonari (13) highlight its SMet diagnostic value in adolescents. On the other hand,
the cut-off point for this study differed for men (8.77) as for women (8.70), which differ from other
works such as Li et al (32), who gave a cut-off point of 8.81; or in the
study by Moon (14), who reported a cut-off of 8.45. Reasons why TyG index may
not be the best indicator for SMet are that, although it includes glucose and triglycerides, it does not
include AC, which some authors consider it as the most important SMet marker (33).
Regarding BMI, it demonstrated the least SMet diagnostic capacity for both sexes. A metanalysis
by Lee et al. (34) reported that BMI was the worst discriminator to predict
diabetes, hypertension, or dyslipidemia. Herrera et al. also reported that BMI was the least precise
measure for coronary disease risk (35). In a study by Thai-Hua (17), other indices, such as VAI surpassed BMI in predicting metabolic
syndrome.
Result interpretations
Among all the different scenarios that could lead us to SMet, one of the most important is visceral
adiposity. In several studies, it has been demonstrated that visceral adipose tissue has a greater rate
of lipolysis and a greater production of adipocytokines, such as interleukin-6, the inhibitor of
plasminogen-1 activator and tissue macrophage activation, which is more related with cardiometabolic
risks in comparison to subcutaneous adipose tissue (36, 37).
At the same time, a release of free fatty acids may cause the accumulation off at
intraorganically, such as liver and pancreas. The latter produces, ultimately, a state of insulin
resistance, increasing the hepatic production of glucose, reduction of hepatic insulin clearance,
increase in abdominal waist, increase of circulating triglycerides, and, finally, all which lead to SMet
(38).
Study limitations
Some limitations should be considered. First, this is a cross-sectional study, which means we cannot evaluate the association of these variables with SMet in a longitudinal form. Second, the database was not collected for the purpose of this study. Furthermore, the survey was carried out in the years 2004-2005, which is possible the abdominal circumference of a similar current population may be different. However, it is important to consider that it offers us a first glimpse of diagnostic performance of variables that have been tested. Third, while the participants are Peruvians from different regions of the country, it is probable that it is not completely representative, but given the characteristics that they may share in common, some inference may be made.
CONCLUSION
The LAP index had the greatest SMet diagnostic performance, for men and women, independent of age, with optimal cut-off points of 59.85 and 53.06, respectively. The LAP index is easy to use and does not require expensive laboratory tests, making it an easy-to-use index in primary care compared to VAI that requires AC, TG, BMI and HDL cholesterol for its calculation. If the current results are confirmed in future research, LAP should be included as an SMet predictor primary health care.
Authorship contributions: The authors participated in the genesis of the idea, project
design, data collection and interpretation, results analysis and drafting of this research work.
Funding sources: Self-financed.
Conflicts of Interest: The authors declare not having conflicts of interest.
Received: August 13, 2021
Approved: December 7, 2021
Correspondence: M.S Jesús Enrique Talavera Ramírez
Address: Universidad Ricardo Palma, Lima, Perú.
Telephone number: +51 959706046
E-mail: enrique7.talav@gmail.com